Literature DB >> 17143955

Effects of ketamine on proinflammatory cytokines and nuclear factor kappaB in polymicrobial sepsis rats.

Xue-Min Song1, Jian-Guo Li, Yan-Lin Wang, Qing Zhou, Zhao-Hui Du, Bao-Hui Jia, Jian-Juan Ke.   

Abstract

AIM: To explore the effects of ketamine on hemo-dynamics, plasma proinflammatory cytokine (TNF-alpha and IL-6) levels and nuclear factor kappa B (NF-kappaB) activation during polymicrobial sepsis.
METHODS: Male Sprague-Dawley rats were subjected to cecal ligation and puncture (CLP) or sham operation. The rats were randomly assigned into four equal groups: sham CLP group, CLP group, ketamine (KT) I group and KT II group. Thirty minutes before CLP, ketamine (5 mg/kg per hour and 10 mg/kg per hour, respectively) was infused continuously through the left femoral vein cannula in KT I group or KT II group. Sham CLP group and CLP group received 0.9% saline only (5 mL/kg per hour). The right femoral artery was cannulated to monitor mean arterial pressure (MAP) and heart rates (HR),and draw blood samples. The proinflammatory cytokine (TNF-alpha and IL-6) levels of plasma were measured using enzyme-linked immunosorbent assays (ELISA). The hepatic NF-kappaB activation was determined by Western blot and HPIAS 2000 image analysis system. Twenty hours after CLP, the rats were killed by right femoral artery phlebotomization.
RESULTS: CLP produced progressive hypotension, and a first increase followed by a decrease in HR. The hypotension was prevented, and the HR was slightly steady in ketamine treated rats. TNF-alpha levels of plasma reached a peak value at 2 h after CLP. Ketamine (KT I group or KT II group) caused a significant decrease compared with CLP group at 2, 5 and 9 h time points after CLP (14.3 +/- 1.9 vs 4.3 +/- 0.9, 9.7 +/- 1.4 vs 4.3 +/- 0.9; 9.3 +/- 1.5 vs 4.3 +/- 0.9, 8.7 +/- 1.4 vs 4.3 +/- 0.9; 6.0 +/- 1.5 vs 5.0 +/- 1.7, 5.3 +/- 0.8 vs 5.0 +/- 1.7; P < 0.01, respectively). The IL-6 levels of plasma firstly ascended and then descended in CLP group, and reached a peak value at 9 h after CLP. Ketamine (KT I group or KT II group) caused a significant decrease compared with CLP group at 5, 9 or 20 h after CLP (135.0 +/- 52.6 vs 60.0 +/- 16.3, 112.5 +/- 52.6 vs 60.0 +/- 16.3; 410.0 +/- 68.7 vs 62.5 +/- 12.5, 250.0 +/- 28.0 vs 62.5 +/- 12.5; 320.0 +/- 25.9 vs 52.5 +/- 10.1, 215.0 +/- 44.6 vs 52.5 +/- 10.1; P < 0.05, respectively). The IL-6 levels of plasma in KT II group were lower than those of KT I group at 9 h after CLP (250.0 +/- 28.0 vs 410.0 +/- 68.7; P < 0.05). In addition, CLP increased hepatic NF-kappaB expression compared with sham CLP. Ketamine suppressed NF-kappaB activation in a dose-dependent manner at 4 h after CLP (237.7 +/- 3.5 vs 246.9 +/- 3.1; P < 0.05).
CONCLUSION: Ketamine stabilizes the hemodynamics, attenuates the proinflammatory cytokine responses, and inhibits hepatic NF-kappaB activation. These findings suggest that ketamine has protective effects against polymicrobial sepsis in rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143955      PMCID: PMC4087497          DOI: 10.3748/wjg.v12.i45.7350

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  17 in total

Review 1.  Definition of sepsis.

Authors:  I Matot; C L Sprung
Journal:  Intensive Care Med       Date:  2001       Impact factor: 17.440

Review 2.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 3.  Pathophysiologic basis of sepsis: considerations for future strategies of intervention.

Authors:  M P Glauser
Journal:  Crit Care Med       Date:  2000-09       Impact factor: 7.598

4.  A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.

Authors:  N C Andrews; D V Faller
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

Review 5.  Sepsis and septic shock--a review of laboratory models and a proposal.

Authors:  K A Wichterman; A E Baue; I H Chaudry
Journal:  J Surg Res       Date:  1980-08       Impact factor: 2.192

6.  Modulation of endotoxin-stimulated TNF-alpha gene expression by ketamine and propofol in cultured human whole blood.

Authors:  G Hoff; I Bauer; B Larsen; M Bauer
Journal:  Anaesthesist       Date:  2001-07       Impact factor: 1.041

7.  Ketamine isomers suppress superantigen-induced proinflammatory cytokine production in human whole blood.

Authors:  C Kawasaki; T Kawasaki; M Ogata; K Nandate; A Shigematsu
Journal:  Can J Anaesth       Date:  2001-09       Impact factor: 5.063

8.  Ketamine suppresses endotoxin-induced NF-kappaB expression.

Authors:  T Sakai; T Ichiyama; C W Whitten; A H Giesecke; J M Lipton
Journal:  Can J Anaesth       Date:  2000-10       Impact factor: 5.063

9.  Ketamine inhibits endotoxin-induced shock in rats.

Authors:  T Taniguchi; K Shibata; K Yamamoto
Journal:  Anesthesiology       Date:  2001-10       Impact factor: 7.892

10.  Effect of ketamine on NF-kappa B activity and TNF-alpha production in endotoxin-treated rats.

Authors:  Jie Sun; Feng Li; Jing Chen; Jianguo Xu
Journal:  Ann Clin Lab Sci       Date:  2004       Impact factor: 1.256

View more
  4 in total

1.  Intravenous anesthetic ketamine attenuates complete Freund's adjuvant-induced arthritis in rats via modulation of MAPKs/NF-κB.

Authors:  Hui Lin; Zhe Wang; Jinmei Shen; Junmei Xu; Hui Li
Journal:  Inflamm Res       Date:  2018-11-30       Impact factor: 4.575

Review 2.  Modeling sepsis in the laboratory: merging sound science with animal well-being.

Authors:  Jean A Nemzek; Kelly M S Hugunin; Mark R Opp
Journal:  Comp Med       Date:  2008-04       Impact factor: 0.982

3.  Ozone preconditioning and exposure to ketamine attenuates hepatic inflammation in septic rats.

Authors:  Wenchong Sun; Ling Pei
Journal:  Arch Med Sci       Date:  2012-06-28       Impact factor: 3.318

Review 4.  Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy.

Authors:  April Ann Cox; Yves Sagot; Gael Hedou; Christina Grek; Travis Wilkes; Aaron I Vinik; Gautam Ghatnekar
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-02       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.